ADAMANTINOMATOUS CRANIOPHARYNGIOMA
Clinical trials for ADAMANTINOMATOUS CRANIOPHARYNGIOMA explained in plain language.
Never miss a new study
Get alerted when new ADAMANTINOMATOUS CRANIOPHARYNGIOMA trials appear
Sign up with your email to follow new studies for ADAMANTINOMATOUS CRANIOPHARYNGIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug FOG-001 takes on Hard-to-Treat cancers
Disease control Recruiting nowThis early-phase trial is testing a new drug, FOG-001, in about 595 people with advanced or metastatic solid tumors, including colorectal, prostate, and liver cancers. The drug is given alone or with other cancer treatments to see if it is safe and shrinks tumors. The study is cu…
Matched conditions: ADAMANTINOMATOUS CRANIOPHARYNGIOMA
Phase: PHASE1, PHASE2 • Sponsor: Parabilis Medicines, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC
-
Arthritis drug shows promise against rare childhood brain tumor
Disease control Recruiting nowThis study tests a drug called tocilizumab, already used for arthritis, in children and young adults with a rare brain tumor called adamantinomatous craniopharyngioma that has come back or is growing. The goal is to see if the drug can shrink the tumor or stop it from growing. Ab…
Matched conditions: ADAMANTINOMATOUS CRANIOPHARYNGIOMA
Phase: PHASE2 • Sponsor: Nationwide Children's Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC